Meeting
2023 ASCO Quality Care Symposium
Engagement of patients with advanced cancer (EPAC) randomized clinical trial: Long-term effects on survival and healthcare use.
Presenter
Manali I. Patel, MD, MS, FASCO, MPH
Stanford University - School of Medicine
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Videos & Slides Details
Session Type
Oral Abstract Session
Session Title
Oral Abstract Session B
Track
Health Care Access, Equity, and Disparities,Palliative and Supportive Care,Survivorship
Sub Track
Interventions and Policies to Optimize Health Equity
Clinical Trial Registration Number
NCT02966509
Citation
JCO Oncol Pract 19, 2023 (suppl 11; abstr 76)
DOI
10.1200/OP.2023.19.11_suppl.76
Abstract #
76
Abstract Disclosures
Similar Videos & Slides
Videos & Slides
2023 ASCO Annual Meeting
Engagement of Patients with Advanced Cancer (EPAC) randomized clinical trial: Long-term effects on survival and healthcare use.
Speaker: Manali I. Patel, MS, MPH
Videos & Slides
2024 ASCO Annual Meeting
Lorlatinib vs crizotinib in treatment-naïve patients with advanced ALK+ non-small cell lung cancer: 5-year progression-free survival and safety from the CROWN study.
Speaker: Benjamin J. Solomon, PhD, MBBS
Videos & Slides
ASCO Media Events
Presentation of Abstract LBA8503, Lorlatinib vs crizotinib in treatment-naive patients with advanced ALK+ non-small cell lung cancer: 5-year progression-free survival and safety from the CROWN study.
Speaker: Benjamin Solomon, PhD, MBBS
Videos & Slides
2023 ASCO Annual Meeting
Association of ctDNA tumor fraction with survival in advanced non-small cell lung cancer (NSCLC) treated with maintenance durvalumab in the UNICANCER SAFIR02-Lung/IFCT1301 trial.
Speaker: Filippo Gustavo Dall'Olio, MD